Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 409

1.

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.

Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM.

PLoS One. 2019 Jun 25;14(6):e0217566. doi: 10.1371/journal.pone.0217566. eCollection 2019.

2.

Buccal jet streaming and dead space determination in the South American lungfish, Lepidosiren paradoxa.

Minto WJ, Giusti H, Glass ML, Klein W, da Silva GSF.

Comp Biochem Physiol A Mol Integr Physiol. 2019 Sep;235:159-165. doi: 10.1016/j.cbpa.2019.05.026. Epub 2019 Jun 10.

PMID:
31195123
3.

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist.

Kevin RC, Anderson L, McGregor IS, Boyd R, Manning JJ, Glass M, Connor M, Banister SD.

Front Pharmacol. 2019 May 29;10:595. doi: 10.3389/fphar.2019.00595. eCollection 2019.

4.

What is medicinal cannabis?

Glass M, Ashton JC.

N Z Med J. 2019 May 3;132(1494):49-56.

PMID:
31048824
5.

An Integrative Review of the Prevalence of Depression among Pediatric Patients with Sickle Cell Disease.

Moody KL, Mercer K, Glass M.

Soc Work Public Health. 2019;34(4):343-352. doi: 10.1080/19371918.2019.1606754. Epub 2019 Apr 29.

PMID:
31033425
6.

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence.

Ibsen MS, Finlay DB, Patel M, Javitch JA, Glass M, Grimsey NL.

Front Pharmacol. 2019 Apr 10;10:350. doi: 10.3389/fphar.2019.00350. eCollection 2019.

7.

Do you feel it now? Route of administration and Δ9-tetrahydrocannabinol-like discriminative stimulus effects of synthetic cannabinoids in mice.

Wiley JL, Lefever TW, Glass M, Thomas BF.

Neurotoxicology. 2019 Jul;73:161-167. doi: 10.1016/j.neuro.2019.04.002. Epub 2019 Apr 3.

PMID:
30953678
8.

Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB1 receptors.

Zhu X, Finlay DB, Glass M, Duffull SB.

Br J Pharmacol. 2019 Jul;176(14):2593-2607. doi: 10.1111/bph.14684. Epub 2019 May 21.

PMID:
30945265
9.

Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.

Bourke CD, Gough EK, Pimundu G, Shonhai A, Berejena C, Terry L, Baumard L, Choudhry N, Karmali Y, Bwakura-Dangarembizi M, Musiime V, Lutaakome J, Kekitiinwa A, Mutasa K, Szubert AJ, Spyer MJ, Deayton JR, Glass M, Geum HM, Pardieu C, Gibb DM, Klein N, Edens TJ, Walker AS, Manges AR, Prendergast AJ.

Sci Transl Med. 2019 Apr 3;11(486). pii: eaav0537. doi: 10.1126/scitranslmed.aav0537.

PMID:
30944164
10.

The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.

Banister SD, Kevin RC, Martin L, Adams A, Macdonald C, Manning JJ, Boyd R, Cunningham M, Stevens MY, McGregor IS, Glass M, Connor M, Gerona RR.

Drug Test Anal. 2019 Jul;11(7):976-989. doi: 10.1002/dta.2583. Epub 2019 May 8.

PMID:
30838752
11.

An intact model for quantifying functional selectivity.

Zhu X, Finlay DB, Glass M, Duffull SB.

Sci Rep. 2019 Feb 22;9(1):2557. doi: 10.1038/s41598-019-39000-z.

12.

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

Singh S, Oyagawa CRM, Macdonald C, Grimsey NL, Glass M, Vernall AJ.

ACS Med Chem Lett. 2019 Jan 30;10(2):209-214. doi: 10.1021/acsmedchemlett.8b00597. eCollection 2019 Feb 14.

PMID:
30783505
13.

Dark Classics in Chemical Neuroscience: Δ9-Tetrahydrocannabinol.

Banister SD, Arnold JC, Connor M, Glass M, McGregor IS.

ACS Chem Neurosci. 2019 May 15;10(5):2160-2175. doi: 10.1021/acschemneuro.8b00651. Epub 2019 Feb 22.

PMID:
30689342
14.

Development of selective, fluorescent cannabinoid type 2 receptor ligands based on a 1,8-naphthyridin-2-(1H)-one-3-carboxamide scaffold.

Cooper AG, Oyagawa CRM, Manning JJ, Singh S, Hook S, Grimsey NL, Glass M, Tyndall JDA, Vernall AJ.

Medchemcomm. 2018 Oct 23;9(12):2055-2067. doi: 10.1039/c8md00448j. eCollection 2018 Dec 1.

PMID:
30647881
15.

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines.

Oyagawa CRM, de la Harpe SM, Saroz Y, Glass M, Vernall AJ, Grimsey NL.

Front Pharmacol. 2018 Nov 20;9:1202. doi: 10.3389/fphar.2018.01202. eCollection 2018. Erratum in: Front Pharmacol. 2019 Apr 05;10:418.

16.

Methicillin-resistant Staphylococcal aureus patellar tendon abscess and septic prepatellar bursitis in an injection drug user.

Glass M, Everist B, Nelson D, Spencer J.

Radiol Case Rep. 2018 Nov 16;14(2):238-241. doi: 10.1016/j.radcr.2018.10.036. eCollection 2019 Feb.

17.

IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner.

Müller S, Glaß M, Singh AK, Haase J, Bley N, Fuchs T, Lederer M, Dahl A, Huang H, Chen J, Posern G, Hüttelmaier S.

Nucleic Acids Res. 2019 Jan 10;47(1):375-390. doi: 10.1093/nar/gky1012.

18.

Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.

Banister SD, Adams A, Kevin RC, Macdonald C, Glass M, Boyd R, Connor M, McGregor IS, Havel CM, Bright SJ, Vilamala MV, Lladanosa CG, Barratt MJ, Gerona RR.

Drug Test Anal. 2019 Feb;11(2):279-291. doi: 10.1002/dta.2491. Epub 2018 Oct 1.

PMID:
30151911
19.

Altered Amygdala Excitation and CB1 Receptor Modulation of Aggressive Behavior in the Neuroligin-3R451C Mouse Model of Autism.

Hosie S, Malone DT, Liu S, Glass M, Adlard PA, Hannan AJ, Hill-Yardin EL.

Front Cell Neurosci. 2018 Aug 3;12:234. doi: 10.3389/fncel.2018.00234. eCollection 2018.

20.

Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).

Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL 3rd, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, Foroud T, Coffey CS, Ecklund D, Riss H, Goßmann J, König F, Kopil CM, Arnedo V, Riley L, Linder C, Dave KD, Jennings D, Seibyl J, Mollenhauer B, Chahine L; Systemic Synuclein Sampling Study (S4) .

J Neuropathol Exp Neurol. 2018 Sep 1;77(9):793-802. doi: 10.1093/jnen/nly056.

PMID:
30107604
21.

The ND10 Complex Represses Lytic Human Herpesvirus 6A Replication and Promotes Silencing of the Viral Genome.

Sanyal A, Wallaschek N, Glass M, Flamand L, Wight DJ, Kaufer BB.

Viruses. 2018 Jul 29;10(8). pii: E401. doi: 10.3390/v10080401.

22.

IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors.

Müller S, Bley N, Glaß M, Busch B, Rousseau V, Misiak D, Fuchs T, Lederer M, Hüttelmaier S.

Nucleic Acids Res. 2018 Jul 6;46(12):6285-6303. doi: 10.1093/nar/gky229.

23.

An evaluation of the operational model when applied to quantify functional selectivity.

Zhu X, Finlay DB, Glass M, Duffull SB.

Br J Pharmacol. 2018 May;175(10):1654-1668. doi: 10.1111/bph.14171. Epub 2018 Mar 30.

24.

Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment.

Cooper AG, MacDonald C, Glass M, Hook S, Tyndall JDA, Vernall AJ.

Eur J Med Chem. 2018 Feb 10;145:770-789. doi: 10.1016/j.ejmech.2017.11.076. Epub 2017 Nov 28.

PMID:
29407590
25.

Risk factors for acquisition of multidrug-resistant Escherichia coli and development of community-acquired urinary tract infections.

Ukah UV, Glass M, Avery B, Daignault D, Mulvey MR, Reid-Smith RJ, Parmley EJ, Portt A, Boerlin P, Manges AR.

Epidemiol Infect. 2018 Jan;146(1):46-57. doi: 10.1017/S0950268817002680. Epub 2017 Dec 12.

PMID:
29229015
26.

The M25 gene products are critical for the cytopathic effect of mouse cytomegalovirus.

Kutle I, Sengstake S, Templin C, Glaß M, Kubsch T, Keyser KA, Binz A, Bauerfeind R, Sodeik B, Čičin-Šain L, Dezeljin M, Messerle M.

Sci Rep. 2017 Nov 14;7(1):15588. doi: 10.1038/s41598-017-15783-x.

27.

Extinction of Contextual Cocaine Memories Requires Cav1.2 within D1R-Expressing Cells and Recruits Hippocampal Cav1.2-Dependent Signaling Mechanisms.

Burgdorf CE, Schierberl KC, Lee AS, Fischer DK, Van Kempen TA, Mudragel V, Huganir RL, Milner TA, Glass MJ, Rajadhyaksha AM.

J Neurosci. 2017 Dec 6;37(49):11894-11911. doi: 10.1523/JNEUROSCI.2397-17.2017. Epub 2017 Oct 31.

28.

Histone chaperone HIRA deposits histone H3.3 onto foreign viral DNA and contributes to anti-viral intrinsic immunity.

Rai TS, Glass M, Cole JJ, Rather MI, Marsden M, Neilson M, Brock C, Humphreys IR, Everett RD, Adams PD.

Nucleic Acids Res. 2017 Nov 16;45(20):11673-11683. doi: 10.1093/nar/gkx771.

29.

Affinity and Efficacy Studies of Tetrahydrocannabinolic Acid A at Cannabinoid Receptor Types One and Two.

McPartland JM, MacDonald C, Young M, Grant PS, Furkert DP, Glass M.

Cannabis Cannabinoid Res. 2017 May 1;2(1):87-95. doi: 10.1089/can.2016.0032. eCollection 2017.

30.

Cannabinoid CB1 and CB2 Receptor Signaling and Bias.

Ibsen MS, Connor M, Glass M.

Cannabis Cannabinoid Res. 2017 Mar 1;2(1):48-60. doi: 10.1089/can.2016.0037. eCollection 2017. Review.

31.

Is the Cannabinoid CB2 Receptor a Major Regulator of the Neuroinflammatory Axis of the Neurovascular Unit in Humans?

Kho DT, Glass M, Graham ES.

Adv Pharmacol. 2017;80:367-396. doi: 10.1016/bs.apha.2017.03.009. Epub 2017 Jun 12. Review.

PMID:
28826541
32.

Functional Selectivity at Cannabinoid Receptors.

Priestley R, Glass M, Kendall D.

Adv Pharmacol. 2017;80:207-221. doi: 10.1016/bs.apha.2017.03.005. Epub 2017 Jun 5. Review.

PMID:
28826535
33.

Real-Time Measurement of Cannabinoid Receptor-Mediated cAMP Signaling.

Hunter MR, Finlay DB, Macdonald CE, Cawston EE, Grimsey NL, Glass M.

Methods Enzymol. 2017;593:43-59. doi: 10.1016/bs.mie.2017.05.001. Epub 2017 Jun 27.

PMID:
28750814
34.

Nuclear domain 10 components upregulated via interferon during human cytomegalovirus infection potently regulate viral infection.

Ashley CL, Glass MS, Abendroth A, McSharry BP, Slobedman B.

J Gen Virol. 2017 Jul;98(7):1795-1805. doi: 10.1099/jgv.0.000858.

PMID:
28745271
35.

Rescue of impaired sociability and anxiety-like behavior in adult cacna1c-deficient mice by pharmacologically targeting eIF2α.

Kabir ZD, Che A, Fischer DK, Rice RC, Rizzo BK, Byrne M, Glass MJ, De Marco Garcia NV, Rajadhyaksha AM.

Mol Psychiatry. 2017 Aug;22(8):1096-1109. doi: 10.1038/mp.2017.124. Epub 2017 Jun 6.

36.

Ethics Simulation in Global Health Training (ESIGHT).

Asao S, Lewis B, Harrison JD, Glass M, Brock TP, Dandu M, Le P.

MedEdPORTAL. 2017 Jun 7;13:10590. doi: 10.15766/mep_2374-8265.10590.

37.

s signalling of the CB1 receptor and the influence of receptor number.

Finlay DB, Cawston EE, Grimsey NL, Hunter MR, Korde A, Vemuri VK, Makriyannis A, Glass M.

Br J Pharmacol. 2017 Aug;174(15):2545-2562. doi: 10.1111/bph.13866. Epub 2017 Jun 19.

38.

"Meth Mouth": An Interdisciplinary Review of a Dental and Psychiatric Condition.

Stanciu CN, Glass M, Muzyka BC, Glass OM.

J Addict Med. 2017 Jul/Aug;11(4):250-255. doi: 10.1097/ADM.0000000000000316.

PMID:
28441274
39.

Ultrastructural characterization of tumor necrosis factor alpha receptor type 1 distribution in the hypothalamic paraventricular nucleus of the mouse.

Glass MJ, Chan J, Pickel VM.

Neuroscience. 2017 Jun 3;352:262-272. doi: 10.1016/j.neuroscience.2017.03.044. Epub 2017 Apr 4.

40.

Standardized Attending Rounds to Improve the Patient Experience: A Pragmatic Cluster Randomized Controlled Trial.

Monash B, Najafi N, Mourad M, Rajkomar A, Ranji SR, Fang MC, Glass M, Milev D, Ding Y, Shen A, Sharpe BA, Harrison JD.

J Hosp Med. 2017 Mar;12(3):143-149. doi: 10.12788/jhm.2694.

PMID:
28272589
41.

Effects of aerial hypoxia and temperature on pulmonary breathing pattern and gas exchange in the South American lungfish, Lepidosiren paradoxa.

da Silva GSF, Ventura DADN, Zena LA, Giusti H, Glass ML, Klein W.

Comp Biochem Physiol A Mol Integr Physiol. 2017 May;207:107-115. doi: 10.1016/j.cbpa.2017.03.001. Epub 2017 Mar 3.

PMID:
28263885
42.

Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity.

Soethoudt M, Grether U, Fingerle J, Grim TW, Fezza F, de Petrocellis L, Ullmer C, Rothenhäusler B, Perret C, van Gils N, Finlay D, MacDonald C, Chicca A, Gens MD, Stuart J, de Vries H, Mastrangelo N, Xia L, Alachouzos G, Baggelaar MP, Martella A, Mock ED, Deng H, Heitman LH, Connor M, Di Marzo V, Gertsch J, Lichtman AH, Maccarrone M, Pacher P, Glass M, van der Stelt M.

Nat Commun. 2017 Jan 3;8:13958. doi: 10.1038/ncomms13958.

43.

Acute effects of temperature and hypercarbia on cutaneous and branchial gas exchange in the South American lungfish, Lepidosiren paradoxa.

Zena LA, Bícego KC, da Silva GS, Giusti H, Glass ML, Sanchez AP.

J Therm Biol. 2017 Jan;63:112-118. doi: 10.1016/j.jtherbio.2016.12.001. Epub 2016 Dec 6.

PMID:
28010808
44.

Cacna1c in the Prefrontal Cortex Regulates Depression-Related Behaviors via REDD1.

Kabir ZD, Lee AS, Burgdorf CE, Fischer DK, Rajadhyaksha AM, Mok E, Rizzo B, Rice RC, Singh K, Ota KT, Gerhard DM, Schierberl KC, Glass MJ, Duman RS, Rajadhyaksha AM.

Neuropsychopharmacology. 2017 Sep;42(10):2032-2042. doi: 10.1038/npp.2016.271. Epub 2016 Dec 6.

45.

Oral Health in Electroconvulsive Therapy: A Neglected Topic.

Muzyka BC, Glass M, Glass OM.

J ECT. 2017 Mar;33(1):12-15. doi: 10.1097/YCT.0000000000000351. Review.

PMID:
27611300
46.

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities.

Longworth M, Banister SD, Mack JBC, Glass M, Connor M, Kassiou M.

Forensic Toxicol. 2016;34:286-303. doi: 10.1007/s11419-016-0316-y. Epub 2016 Apr 27.

47.

Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.

Banister SD, Longworth M, Kevin R, Sachdev S, Santiago M, Stuart J, Mack JB, Glass M, McGregor IS, Connor M, Kassiou M.

ACS Chem Neurosci. 2016 Sep 21;7(9):1241-54. doi: 10.1021/acschemneuro.6b00137. Epub 2016 Jul 27.

PMID:
27421060
48.

What Are the Ethical Issues Facing Global-Health Trainees Working Overseas? A Multi-Professional Qualitative Study.

Harrison JD, Logar T, Le P, Glass M.

Healthcare (Basel). 2016 Jul 13;4(3). pii: E43. doi: 10.3390/healthcare4030043.

49.

Decreased neuron loss and memory dysfunction in pilocarpine-treated rats pre-exposed to hypoxia.

Do Val-da Silva RA, Peixoto-Santos JE, Scandiuzzi RC, Balista PA, Bassi M, Glass ML, Romcy-Pereira RN, Galvis-Alonso OY, Leite JP.

Neuroscience. 2016 Sep 22;332:88-100. doi: 10.1016/j.neuroscience.2016.06.047. Epub 2016 Jun 29.

PMID:
27373771
50.

Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model.

Hunter MR, Grimsey NL, Glass M.

Sci Rep. 2016 Jun 7;6:27316. doi: 10.1038/srep27316.

Supplemental Content

Support Center